Uterine Leiomyoma. Leiomyoma of uterus
Conditions
Interventions
Intervention 1: Intervention group: 6 hours before hysteroscopy for cervix ripening, 200 micrograms of vaginal misoprostol from Samisaz pharmaceutical company is placed in the posterior part of the va
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
25 Years to 75 Years
Inclusion criteria
Inclusion criteria: All non-menopausal nulliparous women or Gravid One women with a history of one cesarean section The age group of 25 to 75 years
Exclusion criteria
Exclusion criteria: people with a history of schizophrenia or epilepsy taking phenothiazines, structural cervical abnormalities such as a history of cervical insufficiency, Müllerian anomaly, and history of conization The unwillingness of people to participate in the study Allergy to Evening primrose oil or misoprostol contraindications for Evening primrose oil or misoprostol using such as coagulation disorders or concomitant consumption of anticoagulants drug
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The cervix dilatation measurement. Timepoint: Once, Before hysteroscopy. Method of measurement: The Hegar dilator size using for hysteroscopy. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSahar Garfami
Tehran University of Medical Sciences
Outcome results
None listed